ADA Assay Kits | Anti-Drug Antibody Detection

Screen for anti-drug antibodies (ADA) with our 330+ immunogenicity assay kits. Designed in bridging ELISA format — the industry-standard approach for detecting ADA against therapeutic antibodies. Each kit includes matched drug-coated plates, detection reagents, and positive control antibodies for reliable immunogenicity assessment in preclinical and clinical sample analysis. All products are designated Research Use Only (RUO) — not intended for diagnostic or therapeutic procedures. RUO

Why Researchers Choose abinScience

Bridging ELISA Format Industry-standard assay architecture: drug-coated capture → ADA binding → drug-labeled detection. Detects all ADA isotypes in a single assay.

Matched Reagent Systems Each kit pairs with our anti-idiotype antibodies (positive controls) and research biosimilar antibodies (calibrators) — enabling complete assay validation.

Broad Drug Coverage ADA kits available for adalimumab, trastuzumab, pembrolizumab, nivolumab, rituximab, bevacizumab, infliximab, and 100+ other approved or pipeline therapeutics.

Translational Ready Validated across serum and plasma matrices from human, cynomolgus monkey, mouse, and rat — supporting preclinical-to-clinical immunogenicity programs.